(Q37078067)

18 August 2017

1 reference

title

Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning (English)

1 reference

18 August 2017

Wolfgang A Weber

1

1 reference

18 August 2017

Anca L Grosu

series ordinal

2

1 reference

18 August 2017

Johannes Czernin

series ordinal

3

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Nature Clinical Practice Oncology

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

160-170

1 reference

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

Molecular (functional) imaging for radiotherapy applications: an RTOG symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Attenuation correction for a combined 3D PET/CT scanner

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

PET-CT image co-registration in the thorax: influence of respiration.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Four-dimensional (4D) PET/CT imaging of the thorax.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Initial experience with FDG-PET/CT in the evaluation of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

The additional value of PET/CT over PET in FDG imaging of oesophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

FDG-PET/CT in re-staging of patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

The role of FDG-PET/CT in the detection of recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Positron emission tomography for radiation treatment planning

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Positron emission tomography as an imaging biomarker

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Role of positron emission tomography in lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1041

7 January 2021

Identifiers

DOI

10.1038/NCPONC1041

1 reference

18 August 2017

1 reference